ArticleNetwork and systems medicine2020
Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules.
Open access · diamondAbstract read
In one paragraph
Article in Network and systems medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 37 citations in OpenAlex.
- Omics Studies in Osteoarthritis: A Review of Molecular Mechanisms and Candidate Molecules.Biomolecules · 2026Review
- Metabolomic profiling reveals distinct and shared biology in COPD and IPF.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients.International journal of molecular sciences · 2025Article
- DisCo P-ad: Distance-Correlation-BasedMetabolites · 2025Article
- Article
- Glucagon infusion alters the circulating metabolome and urine amino acid excretion in dogs.The Journal of endocrinology · 2024Article
- Review
- Review
- Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy.PloS one · 2024Article
- TreeKernel: interpretable kernel machine tests for interactions between -omics and clinical predictors with applications to metabolomics and COPD phenotypes.BMC bioinformatics · 2023Article
- Update on metabolomic findings in COPD patients.ERJ open research · 2023Review
- Bilirubin-associated single nucleotide polymorphism (SNP) and respiratory health outcomes: a mendelian randomization study.Respiratory research · 2023Article
- Applying Next-Generation Sequencing and Multi-Omics in Chronic Obstructive Pulmonary Disease.International journal of molecular sciences · 2023Review
- Air pollution, metabolites and respiratory health across the life-course.European respiratory review : an official journal of the European Respiratory Society · 2022Review
- Metabolome Features of COPD: A Scoping Review.Metabolites · 2022Article
- CCDB: A database for exploring inter-chemical correlations in metabolomics and exposomics datasets.Environment international · 2022Article
- Mechanism-aware imputation: a two-step approach in handling missing values in metabolomics.BMC bioinformatics · 2022Article
- A Metabolomic Severity Score for Airflow Obstruction and Emphysema.Metabolites · 2022Article
- PaIRKAT: A pathway integrated regression-based kernel association test with applications to metabolomics and COPD phenotypes.PLoS computational biology · 2021Article
- Metabolomic Profiling Reveals Sex Specific Associations with Chronic Obstructive Pulmonary Disease and Emphysema.Metabolites · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 12 institutions in 1 country.
Lucas A GillenwaterNational Jewish Health, Denver, Colorado, USA.
Katherine A PratteNational Jewish Health, Denver, Colorado, USA.
Brian D HobbsChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Michael H ChoChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Yonghua ZhuangDepartment of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Eitan Halper-StrombergDepartment of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
Charmion Cruickshank-QuinnAgilent Technologies, Santa Clara, California, USA.
Nichole ReisdorphSkaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Irina PetracheNational Jewish Health, Denver, Colorado, USA.
Wassim W LabakiDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Wanda K O'NealLung Institute/Cystic Fibrosis Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Victor E OrtegaDepartment of Internal Medicine, Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Dean P JonesClinical Biomarkers Laboratory, Division of Pulmonary, Allergy, and Critical Care Medicine, Emory School of Medicine, Atlanta, Georgia, USA.
Karan UppalClinical Biomarkers Laboratory, Division of Pulmonary, Allergy, and Critical Care Medicine, Emory School of Medicine, Atlanta, Georgia, USA.
Sean JacobsonNational Jewish Health, Denver, Colorado, USA.
Gregory MichelottiMetabolon, Inc., Morrisville, North Carolina, USA.
Christine H WendtDepartment of Medicine, University of Minnesota and the VAMC, Minneapolis, Minnesota, USA.
Katerina J KechrisDepartment of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Russell P BowlerNational Jewish Health, Denver, Colorado, USA.
National Jewish Health · USBrigham and Women's Hospital · USColorado School of Public Health · USPulmonary and Allergy Associates · USAgilent Technologies (United States) · USJohns Hopkins University · USMetabolon (United States) · USMinneapolis VA Medical Center · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USWake Forest University · US
Funding
Ceramide-induced Lung Destruction in EmphysemaR01HL077328 · NHLBI · NATIONAL JEWISH HEALTH · PI PETRACHE, IRINA · 2006 to 2024
$8.0MAddressing Sparsity in Metabolomics Data AnalysisU01CA235488 · NCI · UNIVERSITY OF COLORADO DENVER · PI GHOSH, DEBASHIS, KECHRIS-MAYS, KATHERINA · 2018 to 2021
$1.8MMulti-omic Subtyping of Chronic Obstructive Pulmonary DiseaseK08HL136928 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HOBBS, BRIAN DANIEL · 2017 to 2021
$864kNCI NIH HHS U01 CA235488NHLBI NIH HHS K08 HL136928NHLBI NIH HHS R01 HL077328
Abstract
PubMed holds no abstract for this paper.
Indexed as
chronic obstructive pulmonary diseaseintegrated omicsmetabolomic quantitative trait analysismetabolomicsnetwork analysis
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.